NASDAQ · Medical - Healthcare Information Services

Omnicell, Inc. (OMCL) Stock

$35.88 +3.00% NASDAQ: OMCL Healthcare

Valuation

MetricValue
Price$35.88
Market Cap$1.63B
P/E Ratio39.83
P/B Ratio1.20
P/S Ratio1.24
EPS (TTM)$0.44
52-Week High$55.00
52-Week Low$29.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE3.13%
ROA1.96%
ROCE3.80%
Gross Margin43.87%
Operating Margin5.44%
Net Margin3.13%
Debt/Equity0.15
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.1B$1.3B$1.1B$1.1B$1.2B
Operating Profit$90.0M$-2.0M$-19.0M$0$12.0M
Net Profit$78.0M$6.0M$-20.0M$13.0M$2.0M
EPS$1.62$0.12$-0.45$0.27$0.04
Op Margin7.9%-0.2%-1.7%0.0%1.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.1B$2.2B$2.2B$2.1B$2.0B
Total Liabilities$996.0M$1.1B$1.0B$878.0M$743.0M
Cash$349.0M$330.0M$468.0M$369.0M$197.0M
Borrowings$541.0M$617.0M$614.0M$383.0M$204.0M

Latest News

2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down StockStory · Jul 22, 2026 OMCL: Lowering target price to $44.00 Argus Research · Jul 22, 2026 Omnicell to Report Q2 Earnings: OmniSphere in Focus Zacks · Jul 21, 2026 1 Healthcare Stock to Target This Week and 2 We Brush Off StockStory · Jul 20, 2026 The Bull Case For Omnicell (OMCL) Could Change Following New President And ESOP Share Offering Simply Wall St. · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$232.0M$78.0M$181.0M$188.0M$127.0M
Investing Cash Flow$-441.0M$-119.0M$-96.0M$-89.0M$-101.0M
Financing Cash Flow$47.0M$-61.0M$3.0M$-49.0M$-60.0M
Net Cash Flow$-134.0M$-3.0M$148.0M$-102.0M$-148.0M
Free Cash Flow$203.0M$17.0M$140.0M$151.0M$87.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.57
EV / EBITDA13.73
FCF Yield9.13%
Quick Ratio1.43
Interest Coverage14.93
Return 1Y39.54%
Return 3Y-36.75%
Return 5Y-74.00%

Ownership

Insiders Held2.25%
Institutions Held105.83%
Institutions Float Held108.26%
Institutional HolderSharesReport Date
Blackrock Inc.7,207,2182026-03-31
Vanguard Portfolio Management LLC3,214,7662026-03-31
Wellington Management Group, LLP2,707,0462026-03-31
Dimensional Fund Advisors LP2,450,3852026-03-31
Millennium Management Llc2,288,5702026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $338.46 -0.58% 38.93 $4.97T 0.32%
MSFTMicrosoft Corporation $535.97 +2.56% 28.68 $3.98T 0.76%
GOOGLAlphabet Inc. $351.25 +0.85% 16.94 $4.25T 0.26%
AMZNAmazon.com, Inc. $261.49 +2.92% 19.82 $2.81T 0.00%
METAMeta Platforms, Inc. $719.56 -0.18% 27.93 $1.83T 0.28%

About Omnicell, Inc.

Omnicell, Inc. (OMCL) stock trades at $35.88 with a market capitalization of $1.63B. The stock is valued at a price-to-earnings (P/E) ratio of 39.83, price-to-book of 1.20, price-to-sales of 1.24. Over the past 52 weeks the stock has ranged between $29.06 and $55.00, and currently trades 34.8% below its 52-week high.

On profitability, Omnicell, Inc. generates a return on equity (ROE) of 3.13%, return on capital employed of 3.80%, an operating margin of 5.44%, a net profit margin of 3.13%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1173.15 +0.30% JNJ Johnson & Johnson $260.24 +1.47% ABBV AbbVie Inc. $276.46 +1.48% MRK Merck & Company, Inc. Common Stock (new) $146.28 +2.74% UNH UnitedHealth Group Incorporated Common Stock (DE) $381.63 +2.88% NVS Novartis AG $143.79 +0.47% AZN AstraZeneca PLC $159.37 +0.37% TMO Thermo Fisher Scientific Inc $657.30 +0.82% AMGN Amgen Inc. $416.42 +2.20% GILD Gilead Sciences, Inc. $150.73 +2.47% ABT Abbott Laboratories $99.51 +1.04% NVO Novo Nordisk A/S $38.42 +0.62%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides